These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 11717605)

  • 61. Acute toxic effects of sustained-release verapamil in chronic renal failure.
    Pritza DR; Bierman MH; Hammeke MD
    Arch Intern Med; 1991 Oct; 151(10):2081-4. PubMed ID: 1843183
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Sustained-release verapamil in stable angina.
    Kohli RS; Rodrigues EA; Hughes LO; Lahiri A; Raftery EB
    Br J Clin Pract Suppl; 1988 Apr; 60():20-3. PubMed ID: 3151265
    [No Abstract]   [Full Text] [Related]  

  • 63. [Evaluation of the efficacy of verapamil in slow-release preparations in the treatment of stable exertion angina].
    Scrutinio D; Lagioia R; De Toma L; Mangini S; Accettura D; De Nicolò M
    Cardiologia; 1982 Oct; 27(10):963-71. PubMed ID: 6927458
    [No Abstract]   [Full Text] [Related]  

  • 64. Efficacy and safety of verapamil in patients with angina pectoris after 1 year of continuous, high-dose therapy.
    Weiner DA; McCabe CH; Cutler SS; Creager MA; Ryan TJ; Klein MD
    Am J Cardiol; 1983 May; 51(8):1251-5. PubMed ID: 6342351
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Efficacy and safety of verapamil SR 240 mg in essential hypertension: results of a multicentric phase IV study.
    Speders S; Sosna J; Schumacher A; Pfennigsdorf G
    J Cardiovasc Pharmacol; 1989; 13 Suppl 4():S47-9. PubMed ID: 2475686
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Single daily dose of verapamil (COER-24 180/24 mg) in mild and moderate hypertension evaluated by ambulatory blood pressure monitoring].
    Ortega KC; Santello JL; Nobre F; Kohlman Júnior O; Jardim PC; da Costa LS; Rosito GA; Raposo Filho JJ; Oigman W; Mion Júnior D
    Arq Bras Cardiol; 2000 Mar; 74(3):283-90. PubMed ID: 10951830
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Evaluation of the efficacy of verapamil in a slow-release preparation in the treatment of stable exertion angina].
    Scrutinio D; Lagioia R; De Toma L; Mangini S; Accettura D; De Nicolò M; Antuofermo F; Rizzon P
    Cardiologia; 1982 Oct; 27(10):963-71. PubMed ID: 6765260
    [No Abstract]   [Full Text] [Related]  

  • 68. [Verapamil-associated liver injury].
    Odeh M; Oliven A
    Harefuah; 1998 Jan; 134(1):36-7. PubMed ID: 9517278
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Short-term efficacy of oral verapamil in rest angina. A double-blind placebo controlled trial in CCU patients.
    Mehta J; Pepine CJ; Day M; Guerrero JR; Conti CR
    Am J Med; 1981 Dec; 71(6):977-82. PubMed ID: 7032291
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Studies with sustained-release verapamil in essential hypertension.
    Silke B
    Br J Clin Pract Suppl; 1988 Apr; 60():53-7. PubMed ID: 3151272
    [No Abstract]   [Full Text] [Related]  

  • 71. [The toxicity of slow-release verapamil and chronic kidney disease].
    Huelmos A; Alegría E; Vázquez C
    Rev Esp Cardiol; 1994 Nov; 47(11):780. PubMed ID: 7800911
    [No Abstract]   [Full Text] [Related]  

  • 72. [Isoptin Retard. Pharmacokinetics and pharmacodynamics in patients with angina pectoris].
    Jespersen CM
    Ugeskr Laeger; 1990 May; 152(21):1516-8. PubMed ID: 2193448
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Junctional bradycardia with verapamil in renal failure--care required even with mild hyperkalaemia.
    Hegazi MO; Aldabie G; Al-Mutairi S; El Sayed A
    J Clin Pharm Ther; 2012 Dec; 37(6):726-8. PubMed ID: 22568727
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Once-daily verapamil in hypertension: intra-arterial recording of blood pressure.
    Brigden GS; Caruana MP; Heber ME; Raftery EB
    Br J Clin Pract Suppl; 1988 Apr; 60():48-52. PubMed ID: 3151271
    [No Abstract]   [Full Text] [Related]  

  • 75. An objective evaluation of once-daily sustained-release verapamil (480 mg) in chronic stable angina.
    Rodrigues EA; DasGupta P; Hains AD; Raftery EB
    Eur J Clin Pharmacol; 1988; 34(5):531-2. PubMed ID: 3060361
    [No Abstract]   [Full Text] [Related]  

  • 76. Verapamil. An anti-anginal agent.
    Moyer RR
    Minn Med; 1972 Nov; 55(11):1043-5. PubMed ID: 4594260
    [No Abstract]   [Full Text] [Related]  

  • 77. Verapamil in the long-term treatment of angina pectoris.
    Raftos J
    Med J Aust; 1980 Jul; 2(2):78-80. PubMed ID: 7421656
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A pharmacodynamic model of the effects of controlled-onset extended-release verapamil on 24-hour ambulatory blood pressure.
    Lima JJ; Beasley BN; Parker RB; Johnson JA
    Int J Clin Pharmacol Ther; 2005 Apr; 43(4):187-94. PubMed ID: 15966465
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A multicenter study of verapamil in systemic hypertension in Thailand.
    Nontakanun S; Ngarmukos P; Sitthisook S; Jeam-Anukulkit N; Intharakoses A; Tanprasert P; Sansanayudth P; Sriratanaban A; Polsi Y
    Am J Cardiol; 1986 Feb; 57(7):106D-107D. PubMed ID: 3513511
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Hypertrophic gingivitis caused by verapamil].
    Cucchi G; Giustiniani S; Robustelli F
    G Ital Cardiol; 1985 May; 15(5):556-7. PubMed ID: 4054493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.